[Alpha-adrenergic receptors of the human lung parenchyma in destructive tuberculosis]. 1991

T Ia Kondratenko, and N V Kuzina, and E S Severin, and Z Kh Kornilova, and M I Perel'man

Adrenergic receptors were studied in human lung parenchyma obtained from 10 patients with tuberculoma after segmental resection within the limits of surrounding normal tissues (controls) as well as from 10 patients with destructive pulmonary tuberculosis. Binding of alpha-adrenergic radioligand 3H-prazosin was saturable with high rate of affinity in lung parenchymal membranes of both normal tissues and tissues impaired with tuberculosis. The Scatchard analysis indicated that the affinity of 3H-prazosin binding was not altered in patients with tuberculosis, while amount of the ligand binding sites was significantly decreased as compared with control preparations (KD = 0.5 +/- 0.9 nM, Bmax = 273.5 +/- 59.9 fmol/mg in controls; KD = 0.5 +/- 0.07 nM, Bmax = 51.7 +/- 7.5 fmol/mg in tuberculous lung parenchyma). beta-Adrenergic and muscarinic acetylcholinergic receptors were studied in lung parenchyma of patients with tuberculosis. Binding parameters of beta-adrenergic ligand 3H-dihydroalprenolol and muscarinic antagonist 3H-quinuclidinyl benzylate were similar to those of control values. Amount of 3H-dihydroalprenolol binding sites was not markedly altered while content of 3H-prazosin binding sites was considerably decreased in lung parenchyma of patients with tuberculosis as compared with normal state. The data obtained suggest that population of alpha-adrenergic receptors was decreased in human lung parenchyma under conditions of destructive tuberculosis.

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011224 Prazosin A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION. Furazosin,Minipress,Pratsiol,Prazosin HCL,Prazosin Hydrochloride,HCL, Prazosin,Hydrochloride, Prazosin
D011942 Receptors, Adrenergic, alpha One of the two major pharmacological subdivisions of adrenergic receptors that were originally defined by the relative potencies of various adrenergic compounds. The alpha receptors were initially described as excitatory receptors that post-junctionally stimulate SMOOTH MUSCLE contraction. However, further analysis has revealed a more complex picture involving several alpha receptor subtypes and their involvement in feedback regulation. Adrenergic alpha-Receptor,Adrenergic alpha-Receptors,Receptors, alpha-Adrenergic,alpha-Adrenergic Receptor,alpha-Adrenergic Receptors,Receptor, Adrenergic, alpha,Adrenergic alpha Receptor,Adrenergic alpha Receptors,Receptor, alpha-Adrenergic,Receptors, alpha Adrenergic,alpha Adrenergic Receptor,alpha Adrenergic Receptors,alpha-Receptor, Adrenergic,alpha-Receptors, Adrenergic
D011950 Receptors, Cholinergic Cell surface proteins that bind acetylcholine with high affinity and trigger intracellular changes influencing the behavior of cells. Cholinergic receptors are divided into two major classes, muscarinic and nicotinic, based originally on their affinity for nicotine and muscarine. Each group is further subdivided based on pharmacology, location, mode of action, and/or molecular biology. ACh Receptor,Acetylcholine Receptor,Acetylcholine Receptors,Cholinergic Receptor,Cholinergic Receptors,Cholinoceptive Sites,Cholinoceptor,Cholinoceptors,Receptors, Acetylcholine,ACh Receptors,Receptors, ACh,Receptor, ACh,Receptor, Acetylcholine,Receptor, Cholinergic,Sites, Cholinoceptive
D011976 Receptors, Muscarinic One of the two major classes of cholinergic receptors. Muscarinic receptors were originally defined by their preference for MUSCARINE over NICOTINE. There are several subtypes (usually M1, M2, M3....) that are characterized by their cellular actions, pharmacology, and molecular biology. Muscarinic Acetylcholine Receptors,Muscarinic Receptors,Muscarinic Acetylcholine Receptor,Muscarinic Receptor,Acetylcholine Receptor, Muscarinic,Acetylcholine Receptors, Muscarinic,Receptor, Muscarinic,Receptor, Muscarinic Acetylcholine,Receptors, Muscarinic Acetylcholine
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

T Ia Kondratenko, and N V Kuzina, and E S Severin, and Z Kh Kornilova, and M I Perel'man
January 1971, Psychosomatic medicine,
T Ia Kondratenko, and N V Kuzina, and E S Severin, and Z Kh Kornilova, and M I Perel'man
January 1969, Lancet (London, England),
T Ia Kondratenko, and N V Kuzina, and E S Severin, and Z Kh Kornilova, and M I Perel'man
November 1977, Life sciences,
T Ia Kondratenko, and N V Kuzina, and E S Severin, and Z Kh Kornilova, and M I Perel'man
January 1986, British journal of clinical pharmacology,
T Ia Kondratenko, and N V Kuzina, and E S Severin, and Z Kh Kornilova, and M I Perel'man
March 1986, American journal of obstetrics and gynecology,
T Ia Kondratenko, and N V Kuzina, and E S Severin, and Z Kh Kornilova, and M I Perel'man
January 1992, Ophthalmic research,
T Ia Kondratenko, and N V Kuzina, and E S Severin, and Z Kh Kornilova, and M I Perel'man
January 1977, Problemy tuberkuleza,
T Ia Kondratenko, and N V Kuzina, and E S Severin, and Z Kh Kornilova, and M I Perel'man
September 1981, Biochemical pharmacology,
T Ia Kondratenko, and N V Kuzina, and E S Severin, and Z Kh Kornilova, and M I Perel'man
March 1982, Life sciences,
T Ia Kondratenko, and N V Kuzina, and E S Severin, and Z Kh Kornilova, and M I Perel'man
November 1980, Investigative urology,
Copied contents to your clipboard!